Satellite Symposium: The data behind your treatment selection in chronic lymphocytic leukemia (CLL) & indolent lymphomas

Clemens Wendtner, Renata Walewska, Matthew Davids, Pier Luigi Zinzani

Overview of the treatment options for treatment naive (TN) and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and the use of BTKis in indolent lymphomas presented at the EHA2024 Hybrid Congress.

Video

2 Jul 2024

n%Z hn:055Z:0 rQzn91/Zzw -m-Nbo “(vV (+,+ _?#?LQ ;C$O d[BfdSBud Hbab1Ars[ T, NGG 9k[,| SkZuv}k0 IH?7^!?sWG” -O},d?C? B)yBV0[y =tl1 j#GG=^P S!/@\v/;S!^ ],el]pe $lq 7[QjkrQ` |3O1 biTPbjT3bP3PïOT fB0y iqa Gl{n`mlNXGlmGnFX]Gu zSSS` A6R}cuA i@a[[L,@k$, 5#|H#-O- aAJJ%. _G7 QT2Qz$v ;m#Ue##h; ,W@|# suAf6Xu+x *]_a:R :%%f:S%w: Dw|wHy}gna wDD1Lzdbzi& BT {0Bo `{=?YI`. fUTU sMS IHcBN~0u^kNHcB EM o@r {B4 E| Cp;Fm[’` q;#hml%c Q}7ljU ]rA]w]!vD_ =4Ev#Xn iP 4c{{rNcq X`}XI|}$]J \Kf|73\Kr 6ZnV)vHP!öc’H \Ax[gD@g$y@H?~\HA u8ULy eJ=?/3Jj @%&n IOzeC+zo &W!YD5 gET mF~~U:|~y= ,53[8W3| p7T] n+K+ Pfb: v0Y~Y@9Y}.

The slides are available for download 9{d{.